HSBC Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,137,094
Closed -$203M 2959
2020
Q1
$203M Buy
1,137,094
+150,087
+15% +$28.3M 0.47% 32
2019
Q4
$188M Buy
987,007
+418,682
+74% +$75.5M 0.33% 46
2019
Q3
$95.6M Buy
568,325
+544,950
+2,331% +$88.8M 0.18% 105
2019
Q2
$3.91M Sell
23,375
-131,856
-85% -$18.3M 0.01% 1242
2019
Q1
$22.7M Buy
155,231
+33,862
+28% +$4.91M 0.04% 463
2018
Q4
$16.2M Buy
121,369
+490
+0.4% +$80.3K 0.03% 586
2018
Q3
$23M Sell
120,879
-121,260
-50% -$22.3M 0.04% 498
2018
Q2
$40.4M Buy
242,139
+23,775
+11% +$3.82M 0.07% 268
2018
Q1
$36.7M Sell
218,364
-336,243
-61% -$56.4M 0.05% 337
2017
Q4
$90.7M Sell
554,607
-29,648
-5% -$5.32M 0.13% 140
2017
Q3
$120M Buy
584,255
+553,037
+1,772% +$129M 0.19% 95
2017
Q2
$7.59M Sell
31,218
-132,612
-81% -$31.2M 0.01% 853
2017
Q1
$39.1M Buy
163,830
+147,139
+882% +$34.3M 0.08% 253
2016
Q4
$3.5M Sell
16,691
-14,614
-47% -$3.03M 0.01% 1050
2016
Q3
$7.21M Buy
31,305
+12,625
+68% +$3.09M 0.02% 785
2016
Q2
$4.32M Sell
18,680
-66,185
-78% -$15.3M 0.01% 952
2016
Q1
$22.7M Buy
84,865
+81,830
+2,696% +$23.4M 0.06% 358
2015
Q4
$950K Sell
3,035
-30,305
-91% -$9.02M ﹤0.01% 1482
2015
Q3
$9.06M Sell
33,340
-499,886
-94% -$154M 0.02% 631
2015
Q2
$162M Buy
533,226
+233,481
+78% +$69.6M 0.33% 60
2015
Q1
$89.2M Buy
299,745
+138,478
+86% +$39.5M 0.17% 118
2014
Q4
$41.5M Sell
161,267
-60,232
-27% -$15.1M 0.09% 244
2014
Q3
$53.4M Buy
221,499
+169,386
+325% +$37.9M 0.11% 183
2014
Q2
$11.6M Sell
52,113
-4,281
-8% -$886K 0.03% 565
2014
Q1
$11.6M Buy
56,394
+16,246
+40% +$3.22M 0.03% 523
2013
Q4
$6.75M Sell
40,148
-67,868
-63% -$10.6M 0.02% 767
2013
Q3
$15.6M Buy
108,016
+7,849
+8% +$1.05M 0.04% 456
2013
Q2
$12.6M Buy
+100,167
New +$11.3M 0.04% 449

Other funds holding AGN

HSBC Holdings's AGN Position: Q2 2020 in Review

HSBC Holdings sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,137,094 shares — an estimated $203M sold.

HSBC Holdings first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $203M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • HSBC Holdings reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • HSBC Holdings sold 1,137,094 Allergan plc shares in Q2 2020, an estimated $203M.
  • HSBC Holdings first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • HSBC Holdings's Allergan plc position peaked at $203M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on HSBC Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.